Pilot Study to Evaluate Reparixin With Weekly Paclitaxel in Patients With HER 2 Negative Metastatic Breast Cancer (MBC)
Clinical trial NCT02001974 · COMPLETED
Trial details
- NCT number
- NCT02001974
- Sponsor
- Dompé Farmaceutici S.p.A
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-27
- Primary completion
- 2014-06-25
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.